{"id":"https://openalex.org/W4310107875","doi":"https://doi.org/10.1182/blood-2022-159164","title":"Daratumumab Based Response Adapted Therapy for Older Adults with Newly Diagnosed Multiple Myeloma: Interim Analysis of Phase II Study","display_name":"Daratumumab Based Response Adapted Therapy for Older Adults with Newly Diagnosed Multiple Myeloma: Interim Analysis of Phase II Study","publication_year":2022,"publication_date":"2022-11-15","ids":{"openalex":"https://openalex.org/W4310107875","doi":"https://doi.org/10.1182/blood-2022-159164"},"language":"en","primary_location":{"id":"doi:10.1182/blood-2022-159164","doi":"https://doi.org/10.1182/blood-2022-159164","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2022-159164","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5077110117","display_name":"Rachid Baz","orcid":"https://orcid.org/0000-0003-4538-4733","observed_orcids":["https://orcid.org/0000-0003-4538-4733"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Rachid C. Baz","raw_affiliation_strings":["1Department of Malignant Hematology, Moffitt cancer center and research institute, tampa, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Department of Malignant Hematology, Moffitt cancer center and research institute, tampa, FL","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009314752","display_name":"Jongphil Kim","orcid":"https://orcid.org/0000-0002-7430-2226","observed_orcids":["https://orcid.org/0000-0002-7430-2226"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jongphil Kim","raw_affiliation_strings":["2Department of Biostatistics and Bioinformatics, H. Lee Moffitt Cancer Center and Research Institutte, Tampa, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Department of Biostatistics and Bioinformatics, H. Lee Moffitt Cancer Center and Research Institutte, Tampa, FL","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Christine Sam","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Christine Sam","raw_affiliation_strings":["3Senior Adult Oncology Program, H.Lee Moffitt Cancer Center, Tampa, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Senior Adult Oncology Program, H.Lee Moffitt Cancer Center, Tampa, FL","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087190330","display_name":"Brandon Jamaal Blue","orcid":"https://orcid.org/0000-0003-0639-3768","observed_orcids":["https://orcid.org/0000-0003-0639-3768"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Brandon J. Blue","raw_affiliation_strings":["4Department of Malignant Hematology, Moffitt Cancer Center, Tampa, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"4Department of Malignant Hematology, Moffitt Cancer Center, Tampa, FL","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078562057","display_name":"Sonila Toska","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sonila Toska","raw_affiliation_strings":["5Department of Malignant Hematology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"5Department of Malignant Hematology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058709546","display_name":"Aaron Collier","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Aaron Collier","raw_affiliation_strings":["5Department of Malignant Hematology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"5Department of Malignant Hematology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064581434","display_name":"Jason B. Brayer","orcid":"https://orcid.org/0000-0003-1126-2279","observed_orcids":["https://orcid.org/0000-0003-1126-2279"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jason Brayer","raw_affiliation_strings":["5Department of Malignant Hematology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"5Department of Malignant Hematology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082565225","display_name":"Ariel Felipe Grajales-Cruz","orcid":"https://orcid.org/0000-0003-0999-1771","observed_orcids":["https://orcid.org/0000-0003-0999-1771"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ariel F Grajales-Cruz","raw_affiliation_strings":["5Department of Malignant Hematology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"5Department of Malignant Hematology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087799564","display_name":"Melissa Alsina","orcid":"https://orcid.org/0000-0003-4946-823X","observed_orcids":["https://orcid.org/0000-0003-4946-823X"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Melissa Alsina","raw_affiliation_strings":["6Moffitt Cancer Center, Tampa, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"6Moffitt Cancer Center, Tampa, FL","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070118399","display_name":"Ariosto Siqueira Silva","orcid":"https://orcid.org/0000-0003-3237-9986","observed_orcids":["https://orcid.org/0000-0003-3237-9986"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ariosto Siqueira Silva","raw_affiliation_strings":["7Department of Cancer Physiology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"7Department of Cancer Physiology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5053572690","display_name":"Kenneth H. Shain","orcid":"https://orcid.org/0000-0003-4178-8888","observed_orcids":["https://orcid.org/0000-0003-4178-8888"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kenneth H. Shain","raw_affiliation_strings":["5Department of Malignant Hematology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"5Department of Malignant Hematology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL","institution_ids":["https://openalex.org/I3019308854"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I3019308854"],"apc_list":{"value":2500,"currency":"USD","value_usd":2500},"apc_paid":null,"fwci":0.1823,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":{"value":0.52822118,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":93},"biblio":{"volume":"140","issue":"Supplement 1","first_page":"7313","last_page":"7314"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11221","display_name":"Bone health and treatments","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/daratumumab","display_name":"daratumumab","score":0.9570000171661377},{"id":"https://openalex.org/keywords/newly-diagnosed-multiple-myeloma","display_name":"newly diagnosed multiple myeloma","score":0.9800000190734863},{"id":"https://openalex.org/keywords/older-adults","display_name":"older adults","score":0.9810000061988831},{"id":"https://openalex.org/keywords/lenalidomide","display_name":"lenalidomide","score":0.8880000114440918},{"id":"https://openalex.org/keywords/bortezomib","display_name":"bortezomib","score":0.902999997138977},{"id":"https://openalex.org/keywords/dexamethasone","display_name":"dexamethasone","score":0.9359999895095825},{"id":"https://openalex.org/keywords/response-adapted-therapy","display_name":"response-adapted therapy","score":0.9169999957084656},{"id":"https://openalex.org/keywords/frailty","display_name":"frailty","score":0.8270000219345093},{"id":"https://openalex.org/keywords/geriatric-assessment","display_name":"geriatric assessment","score":0.7720000147819519},{"id":"https://openalex.org/keywords/timed-up-and-go-test","display_name":"Timed Up and Go test","score":0.7730000019073486},{"id":"https://openalex.org/keywords/drug-sensitivity-assay","display_name":"drug sensitivity assay","score":0.4650000035762787},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.5630000233650208},{"id":"https://openalex.org/keywords/overall-response-rate","display_name":"overall response rate","score":0.8410000205039978},{"id":"https://openalex.org/keywords/high-risk-cytogenetics","display_name":"high-risk cytogenetics","score":0.5260000228881836},{"id":"https://openalex.org/keywords/17p-deletion","display_name":"17p deletion","score":0.8190000057220459}],"concepts":[{"id":"https://openalex.org/C2781119759","wikidata":"https://www.wikidata.org/wiki/Q5222113","display_name":"Daratumumab","level":4,"score":0.8060200214385986},{"id":"https://openalex.org/C2776063141","wikidata":"https://www.wikidata.org/wiki/Q425681","display_name":"Lenalidomide","level":3,"score":0.7984355688095093},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7741923332214355},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5859104990959167},{"id":"https://openalex.org/C2777478702","wikidata":"https://www.wikidata.org/wiki/Q419319","display_name":"Bortezomib","level":3,"score":0.5653893947601318},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.5230818390846252},{"id":"https://openalex.org/C2776364478","wikidata":"https://www.wikidata.org/wiki/Q467635","display_name":"Multiple myeloma","level":2,"score":0.5156732797622681},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.48870542645454407},{"id":"https://openalex.org/C2778524551","wikidata":"https://www.wikidata.org/wiki/Q7227206","display_name":"Pomalidomide","level":4,"score":0.46836817264556885},{"id":"https://openalex.org/C2781413609","wikidata":"https://www.wikidata.org/wiki/Q7308373","display_name":"Regimen","level":2,"score":0.4450586438179016},{"id":"https://openalex.org/C2778336483","wikidata":"https://www.wikidata.org/wiki/Q5090632","display_name":"Chemotherapy regimen","level":3,"score":0.4374420940876007},{"id":"https://openalex.org/C2779050716","wikidata":"https://www.wikidata.org/wiki/Q4826373","display_name":"Autologous stem-cell transplantation","level":3,"score":0.4257250726222992},{"id":"https://openalex.org/C61943457","wikidata":"https://www.wikidata.org/wiki/Q6046661","display_name":"Interim analysis","level":3,"score":0.42462679743766785},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.24334010481834412},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.19372320175170898}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood-2022-159164","doi":"https://doi.org/10.1182/blood-2022-159164","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2022-159164","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4405041898","https://openalex.org/W7093121773","https://openalex.org/W4405052466","https://openalex.org/W4310107743","https://openalex.org/W2904405349","https://openalex.org/W2911782837","https://openalex.org/W4405043259","https://openalex.org/W4405034690","https://openalex.org/W7093121497","https://openalex.org/W7160555743"],"abstract_inverted_index":{"Introduction":[0],"The":[1,140,214,249,389,449,477],"combination":[2,37],"of":[3,101,119,128,142,231,277,316,321,338,361,367,418,421,475,488,504,527,553,567],"daratumumab":[4,49],"(DARA),":[5],"lenalidomide":[6,35],"(Len)":[7],"and":[8,66,71,79,89,114,151,168,170,194,208,238,257,275,282,295,364,385,394,467,469,524,561],"dexamethasone":[9,36],"(Dex)":[10],"is":[11,40],"an":[12,303],"FDA":[13],"approved":[14],"therapy":[15,53,357,363,460,510,535],"for":[16,54,75,95,328,398,536],"older":[17,55,537],"adults":[18,56,538],"with":[19,57,302,308,375,519,539],"newly":[20],"diagnosed":[21],"multiple":[22],"myeloma":[23],"(NDMM)":[24],"based":[25,50,507],"on":[26,108,183,186,424],"the":[27,99,117,135,148,192,371,433,551],"MAIA":[28],"study.":[29],"A":[30],"less":[31,120,376],"intense":[32],"bortezomib":[33],"(Bort)":[34],"(VRD":[38],"lite)":[39],"also":[41],"used.":[42],"We":[43],"thought":[44],"to":[45,63,134,190,197,459,559],"investigate":[46],"a":[47,122,344,365,378,416,520],"personalized":[48],"response":[51,103,196,219,329,346,392,400,426,508,522,533,558],"adapted":[52,401,427,509,534],"NDMM.":[58],"Methods":[59],"Patients":[60],"were":[61,67,176,247,259,266],"required":[62],"have":[64,332],"NDMM":[65,540],"age":[68,251],"over":[69],"65":[70],"not":[72,333],"deemed":[73],"candidates":[74],"high":[76,521],"dose":[77,113,360],"chemotherapy":[78],"autologous":[80],"stem":[81],"cell":[82,206],"transplant.":[83],"Eligible":[84],"patients":[85,246,278,306,325,331,341,350,373,381,489],"received":[86],"subcutaneous":[87],"DARA":[88,109,137,198,232,322,506,560],"Dex":[90,110,138],"(20":[91],"mg":[92],"PO":[93],"weekly)":[94],"2":[96,229,319,336],"cycles:":[97],"in":[98,116,272,287,299,314,407,473,486,513,531,557,563],"event":[100,118],"partial":[102,123,345],"or":[104,130,144,347],"better,":[105],"patient":[106,355,517],"continued":[107],"per":[111,147,220,264],"usual":[112,136],"schedule,":[115],"than":[121,377],"response,":[124],"frailty":[125,164],"adjusted":[126],"dosing":[127],"Len":[129,143],"Bort":[131,145],"was":[132,146,217,252,284,297,312,396,439,447],"added":[133,384],"regimen.":[139],"choice":[141],"treating":[149],"physician":[150],"informed":[152],"by":[153],"Ex":[154],"Vivo":[155],"drug":[156],"sensitivity":[157],"assay.":[158],"Modified":[159],"geriatric":[160],"assessment":[161],"(including":[162],"IMWG":[163,221,265],"score,":[165],"timed":[166],"up":[167,281,423],"go)":[169],"bone":[171],"marrow":[172],"biopsy":[173],"(for":[174],"correlatives)":[175],"performed":[177],"at":[178,204,436,455],"screening":[179],"as":[180,182],"well":[181],"C2D22.":[184],"Capitalizing":[185],"this":[187,399,425,505,514,532,564],"unique":[188,565],"opportunity":[189],"examine":[191],"tumor":[193],"immune":[195],"Dex,":[199,323],"additional":[200,304],"correlative":[201,548],"studies":[202,549],"looking":[203],"single":[205],"RNAseq":[207],"multi-parameter":[209],"flow":[210],"cytometry":[211],"are":[212,326,511],"included.":[213],"primary":[215],"endpoint":[216],"best":[218,391],"criteria.":[222],"Secondary":[223],"endpoints":[224],"included":[225,461,490],"PFS,":[226],"ORR":[227],"after":[228,358],"cycles":[230,320,337],"Dex.":[233],"Result:":[234],"Between":[235],"November":[236],"2019":[237],"July":[239],"2022":[240],"(the":[241],"data":[242],"cutoff":[243],"date),":[244],"25":[245],"enrolled.":[248],"median":[250,417],"79":[253],"years":[254],"(range":[255],"71-88)":[256],"13":[258],"males":[260],"(52%).":[261],"Frailty":[262],"score":[263],"0":[267],"(fit),":[268],"1":[269,354,359,437],"(unfit),":[270],"2+(frail)":[271],"16%,":[273],"32%,":[274],"52%":[276],"respectively.":[279,414],"Timed":[280],"go":[283],"prolonged":[285],"(>10s)":[286],"7":[288],"(35%)":[289,342],"patients.":[290,317,476,568],"High":[291],"risk":[292],"FISH":[293],"(t(4;14)":[294],"del17p)":[296],"noted":[298,313],"3":[300,408],"(12%)":[301],"12":[305],"(48%)":[307],"gain":[309],"1q/Amp1q.":[310],"RISS3":[311],"16%":[315],"After":[318,415],"23":[324],"evaluable":[327],"(2":[330],"yet":[334],"completed":[335],"therapy);":[339],"8":[340],"had":[343,351,382,430],"better":[348],"(no":[349],"progressive":[352,431],"disease,":[353,432],"discontinued":[356],"study":[362],"diagnosis":[366],"disseminated":[368],"tuberculosis).":[369],"Of":[370],"14":[372,410],"(61%)":[374],"PR,":[379],"9":[380],"len":[383],"5":[386,412,429],"bort":[387],"added.":[388],"overall":[390],"(PR":[393],"better)":[395],"95%":[397],"strategy":[402],"including":[403],"CR/sCR,":[404],"VGPR,":[405],"PR":[406],"(13%),":[409],"(61%),":[411],"(21%)":[413],"14.7":[419],"months":[420],"follow":[422],"therapy,":[428],"estimated":[434],"PFS":[435],"year":[438],"90%":[440],"(95%CI":[441],"65-97.4).":[442],"Overall,":[443],"no":[444],"unexpected":[445],"toxicity":[446],"noted.":[448],"most":[450,478],"common":[451,479],"grade":[452,483],"3+":[453],"AE":[454,484],"least":[456],"possibly":[457,480],"related":[458,481],"neutropenia,":[462],"anemia,":[463],"diarrhea,":[464],"hyperglycemia,":[465],"agitation":[466],"confusion":[468],"hypertension":[470],"each":[471],"occurring":[472,485],"4%":[474],"any":[482],">25%":[487],"hyperglycemia":[491],"80%,":[492],"diarrhea":[493],"36%,":[494],"neutropenia":[495],"28%,":[496,498],"insomnia":[497],"fatigue":[499],"28%":[500],"Conclusions:":[501],"Preliminary":[502],"results":[503],"encouraging":[512],"mostly":[515],"frail":[516],"population":[518,566],"rate":[523,526],"low":[525],"severe":[528],"AE.":[529],"Enrollment":[530],"continues.":[541],"With":[542],"longer":[543],"follow-up,":[544],"we":[545],"will":[546],"integrate":[547],"evaluating":[550],"accuracy":[552],"ex":[554],"vivo":[555],"predictions":[556],"combinations":[562],"Figure":[569],"1View":[570,573],"largeDownload":[571,574],"PPTFigure":[572],"PPT":[575],"Close":[576],"modal":[577]},"counts_by_year":[{"year":2023,"cited_by_count":1}],"updated_date":"2026-10-01T08:54:57.152042","created_date":"2022-11-30T00:00:00"}